Home Biosimilar Antibodies Immunology & Inflammation CCR Plozalizumab (Anti-CCR2 / CD192) For research use only.
Not for use in humans.

Plozalizumab (Anti-CCR2 / CD192)

Synonyms: MLN-1202

Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.

Plozalizumab (Anti-CCR2 / CD192)

Click to purchase the isotype control of Plozalizumab (Anti-CCR2 / CD192)

Purity & Quality Control

Batch: A256901 Purity: 99% Protein concentration: 4.13mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CCR Inhibitors

Biological Activity

Description Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.

Product Details

CAS No. 1610761-46-0
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Plozalizumab (Anti-CCR2 / CD192) | Plozalizumab (Anti-CCR2 / CD192) supplier | purchase Plozalizumab (Anti-CCR2 / CD192) | Plozalizumab (Anti-CCR2 / CD192) cost | Plozalizumab (Anti-CCR2 / CD192) manufacturer | order Plozalizumab (Anti-CCR2 / CD192) | Plozalizumab (Anti-CCR2 / CD192) distributor